|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 6 |
| 2 | Management of hyperglycemia in type 2 diabetes:a patient-centered approach:position statement of the American Diabetes Association(ADA)and the European Association for the Study of Diabetes(EASD)显示文摘 | INZUCCHI S E BERGENSTAL R M BUSE J B | 2012 | Diabetes Care2012，35，6： | 1 |
| 3 | Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea显示文摘 | Bergenstal R Lewin A Bailey T | 2009 | Curr Med Res Opin2009，25，1： | 1 |
| 4 | Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association 显示文摘 | Skyler J S Bergenstal R Bonow R O | 2009 | Circulation2009，119，2： | 1 |
| 5 | Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin Al C levels in T1 Dexchange clinic registry participants显示文摘 | Miller K M Beck R Bergenstal R | 2013 | Diabetes Care2013，36，7： | 1 |
| 6 | Examination of cardiovascular outcomes with alogliptin versus standard of care in patients with type-2 diabetes mellitus and acute coronary syndrome (EXAMINE):a cardiovascular safety study of the dipeptidyl peptidase 4 inhibitor alogliptin in patients with type-2 diabetes with acute coronary syndrome显示文摘 | WHITE W B BAKRIS G L BERGENSTAL R M | 2011 | Am Heart J2011，162，4： | 1 |
| 7 | Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA Diabetes Trials: a position statement of the American Diabetes Association and a Scientific Statement of the American College of Cardiology Foundation and the American Heart Association显示文摘 | Skyler JS Bergenstal R Bonow RO | 2009 | J Am Coil Cardiol2009，53，3： | 1 |
| 8 | Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzucchi Silvio E Bergenstal Richard M Buse John B Diamant Michaela Ferrannini Ele Nauck Michael Peters Anne L Tsapas Apostolos Wender Richard Matthews David R | 2012 | EN2012，，3： | 1 |
| 9 | Management of hyperglycemia in type 2 diabetes,2015:a patient-centered approach:update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes显示文摘 | Inzucchi S E Bergenstal R M Buse J B | 2015 | Diabetes Care2015，38，1： | 1 |
| 10 | Intensive glycemic control and the prevention of cardiovascular disease events: implications of the ACCORD, ADVANCE, and VA Diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association显示文摘 | Skyler JS Bergenstal R Bonow RO | 2009 | Diabetes Care2009，，： | 1 |
| 11 | Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes显示文摘 | Bergenstal R M Tamborlane W V Ahmann A | 2010 | N Engl J Med2010，363，4： | 1 |
| 12 | Exenatide once weekly improved glycaemic control,cardiometabolic risk factors and a composite index of an Hb A1c<7%,without weight gain or hypoglycaemia,over52 weeks显示文摘 | Bergenstal R M Li Y Porter T K | 2013 | Diabetes Obesity&Metabolism2013，15，3： | 1 |
| 13 | Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association显示文摘 | Skyler JS Bergenstal R Bonow RO | | Diabetes Care0，32，1： | 1 |
| 14 | Detection of hypoglycemia with con- tinuous interstitial and traditional blood glucose monitoring using the FreeStyle Navigator Continuous Glucose Monitoring System 显示文摘 | Mc Garraugh G Bergenstal R | 2009 | Diabetes Technol Ther2009，11，3： | 1 |
| 15 | Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea显示文摘 | BERGENSTAL R LEWIN A BAILEY T | 2009 | Curr Med Res Opin2009，25，1： | 1 |
| 16 | Management of hyperglycemia in type 2 diabetes: a patient-centered approach position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)显示文摘 | Inzueehi S E Bergenstal R M Buse J B | 2012 | Diabetes Care2012，35，6： | 1 |
| 17 | Identifying variablesassociated with inaccurate self-monitoring of bloodglucose: proposedguidelines to improve accuracy显示文摘 | Bergenstal R Pearson J Cembrowski GS | 2000 | Diabetes Educ2000，26，6： | 1 |
| 18 | Management of hyperglycemia in type 2 diabetes:a patient-centered approach posit ion st atement of t he A mer ica n Diabetes Associat ion(ADA)and the European Association for the Study of Diabetes(EASD)显示文摘 | In z ucchi SE Bergenst al R M Buse J B | 2012 | Diabetes Care2012，35，6： | 1 |
| 19 | Use of twicedaily exenatide in basal insulin-treated patients with type 2diabetes:a randomized,controlled trial显示文摘 | Buse J B Bergenstal R M Glass L C | 2011 | Ann Intern Med2011，154，2： | 1 |
| 20 | Management of hyperglycemia in type 2 diabetes,2015:a patient-centered approach:update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes显示文摘 | Inzucchi S E Bergenstal R M Buse J B | 2015 | Diabetes Care2015，38，1： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员